S23-196 Pioneering Targeted Gene Therapy for Treatment of Glaucoma and Inner Retinal Disorders Stanford researchers have developed a pioneering gene therapy by targeting reactive astrocytes in the optic nerve head (ONH) and modulating cyclic adenosine monophosphate (cAMP) levels for targeted treatment of glaucoma and other retinal disorders. Jeffrey Goldberg Evan Cameron Anna Toth
S22-449 Enhanced light gated potassium selective Channelrhodopsin Researchers at Stanford have discovered long sought after light gated potassium selective channelrhodopsins., HcKCR1 and HcKCR2. Karl Deisseroth Yoon Seok Kim Charu Ramakrishnan Hideaki Kato Seiya TAJIMA